How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?

Susanna Meade Emma RoutledgeEsha SharmaSailish HonapShuvra RaySimon H C AndersonJeremy SandersonJoel MawdsleyPeter M Irving Mark A Samaan

Published in: Frontline gastroenterology (2022)

2 or a greater than 50% reduction, as set out by STRIDE-II, is associated with reduced rates of overall treatment failure including CD-related surgery.

Keyphrases

minimally invasive
healthcare
primary care
combination therapy
coronary artery bypass
atrial fibrillation
drug induced